Cosmo Pharmaceuticals NV banner

Intrinsic Value

The intrinsic value of Cosmo Pharmaceuticals NV (0RGI) under the Base Case is CHF per share. Compared with the current market price of 53.4 CHF, the stock appears .

The intrinsic value is the average of valuations using the DCF method and multiples.

Do our valuations actually work? See backtest results .

0RGI Intrinsic Value

What one share is worth in the bear, base and bull cases.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Intrinsic value for the past 4 months is hidden
Alert me when 0RGI is below its intrinsic value
Today Hidden ·
Alternatives to 0RGI

Fundamental Analysis

What Cosmo Pharmaceuticals Does

Pharmaceuticals Health Care

Cosmo Pharmaceuticals is a specialty drug company focused on digestive health and endoscopy. It develops medicines and medical products used to treat gastrointestinal conditions and to help doctors inspect and treat the colon and other parts of the digestive tract. Its products are aimed mainly at hospitals, gastroenterologists, and sometimes pharmacies, depending on the product and market.

Headquarters
Ireland IE
Employees
325
IPO date
May 18, 2016
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue 0RGI Research

Decided on Cosmo Pharmaceuticals? Get an email when 0RGI reaches the price you’d buy at. Free with an account.

Other Cosmo Pharmaceuticals listings

What is the Intrinsic Value of one 0RGI stock?

The intrinsic value for Cosmo Pharmaceuticals NV (0RGI) under the Base Case is CHF.

Is 0RGI stock undervalued or overvalued?

Compared with the current market price of 53.4 CHF, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top